232 related articles for article (PubMed ID: 31265972)
1. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
2. Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
Poon DMC; Kam MKM; Johnson D; Mo F; Tong M; Chan ATC
Head Neck; 2021 Jun; 43(6):1711-1720. PubMed ID: 33576030
[TBL] [Abstract][Full Text] [Related]
3. Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.
Huang H; Miao J; Xiao X; Hu J; Zhang G; Peng Y; Lu S; Liang Y; Huang S; Han F; Deng X; Zhao C; Wang L
Radiother Oncol; 2022 Oct; 175():1-9. PubMed ID: 35817320
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
5. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
Li Y; Zhao C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
[TBL] [Abstract][Full Text] [Related]
8. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
9. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
Kam MK; Leung SF; Zee B; Chau RM; Suen JJ; Mo F; Lai M; Ho R; Cheung KY; Yu BK; Chiu SK; Choi PH; Teo PM; Kwan WH; Chan AT
J Clin Oncol; 2007 Nov; 25(31):4873-9. PubMed ID: 17971582
[TBL] [Abstract][Full Text] [Related]
11. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
13. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
[No Abstract] [Full Text] [Related]
16. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Bian X; Song T; Wu S
Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
[TBL] [Abstract][Full Text] [Related]
18. Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
Xiang L; Rong JF; Xin-Chen ; Li XY; Zheng Y; Ren PR; Lin S; Wen QL; He LJ; Zhang JW; Shang CL; Yang HR; Fan J; Pang HW; Zhang J; Tan BX; Zhang L; Du XB; Wen SM; Jiang L; Qin G; Wu JB
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):914-924. PubMed ID: 37356553
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]